Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evanthia Galanis

Showing results (41-50 of 196) with videos related to

Pageof 20
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 28, 2009
Converting tumor-specific markers into reporters of oncolytic virus infectionIanko D Iankov, Matthew L Hillestad, Allan B Dietz, et al.
Neuro-Oncology|February 7, 2012
Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastomaAdam W Studebaker, Brian Hutzen, Christopher R Pierson, et al.
BMC Cancer|November 9, 2012
Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodineBrian Hutzen, Christopher R Pierson, Stephen J Russell, et al.
Current Oncology Reports|December 3, 2010
Incorporation of biomarker assessment in novel clinical trial designs: personalizing brain tumor treatmentsEvanthia Galanis, Wenting Wu, Jann Sarkaria, et al.
Neuro-Oncology|May 25, 2010
Treatment of medulloblastoma with a modified measles virusAdam W Studebaker, Cole R Kreofsky, Christopher R Pierson, et al.
Cancer|February 27, 2008
High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous systemPaula Gill, Mark Litzow, Jan Buckner, et al.
The Journal of Gene Medicine|October 2, 2004
Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomasCory Allen, Cari McDonald, Caterina Giannini, et al.
Current Cancer Drug Targets|February 24, 2017
Clinical Trials with Oncolytic Measles Virus: Current Status and Future ProspectsPavlos Msaouel, Mateusz Opyrchal, Angela Dispenzieri, et al.
Virus Research|December 26, 2012
Neutralization capacity of measles virus H protein specific IgG determines the balance between antibody-enhanced infectivity and protection in microglial cellsIanko D Iankov, Alan R Penheiter, Guy E Griesmann, et al.
Neuro-Oncology|August 16, 2022
Translational significance of CDKN2A/B homozygous deletion in isocitrate dehydrogenase-mutant astrocytomaShannon P Fortin Ensign, Robert B Jenkins, Caterina Giannini, et al.
Pageof 20

Showing results (41-50 of 196) with videos related to

Sort By:
Pageof 20
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 28, 2009
Converting tumor-specific markers into reporters of oncolytic virus infectionIanko D Iankov, Matthew L Hillestad, Allan B Dietz, et al.
Neuro-Oncology|February 7, 2012
Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastomaAdam W Studebaker, Brian Hutzen, Christopher R Pierson, et al.
BMC Cancer|November 9, 2012
Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodineBrian Hutzen, Christopher R Pierson, Stephen J Russell, et al.
Current Oncology Reports|December 3, 2010
Incorporation of biomarker assessment in novel clinical trial designs: personalizing brain tumor treatmentsEvanthia Galanis, Wenting Wu, Jann Sarkaria, et al.
Neuro-Oncology|May 25, 2010
Treatment of medulloblastoma with a modified measles virusAdam W Studebaker, Cole R Kreofsky, Christopher R Pierson, et al.
Cancer|February 27, 2008
High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous systemPaula Gill, Mark Litzow, Jan Buckner, et al.
The Journal of Gene Medicine|October 2, 2004
Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomasCory Allen, Cari McDonald, Caterina Giannini, et al.
Current Cancer Drug Targets|February 24, 2017
Clinical Trials with Oncolytic Measles Virus: Current Status and Future ProspectsPavlos Msaouel, Mateusz Opyrchal, Angela Dispenzieri, et al.
Virus Research|December 26, 2012
Neutralization capacity of measles virus H protein specific IgG determines the balance between antibody-enhanced infectivity and protection in microglial cellsIanko D Iankov, Alan R Penheiter, Guy E Griesmann, et al.
Neuro-Oncology|August 16, 2022
Translational significance of CDKN2A/B homozygous deletion in isocitrate dehydrogenase-mutant astrocytomaShannon P Fortin Ensign, Robert B Jenkins, Caterina Giannini, et al.
Pageof 20